Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effects on inflammatory mediators in VATS
NCT02439905Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in reperfusion injury (IRI), sponsored by National Taiwan University Hospital. Started May 2015; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02439905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02439905.